FierceBiotech and FiercePharma Jobs
Research Associate, In Vivo Pharmacology - Dicerna
Categories: Research
Website: http://www.dicerna.com
Position Description
Join an exciting new company engaged in the discovery and development of novel RNAi-based therapeutics. We are seeking a motivated BS/MS scientist to perform in vivo pharmacology research to support the selection and development of therapeutic agents for several ongoing drug discovery programs in oncology, metabolic disease and virology.
Background and Skill Requirements:
• In vivo pharmacology experience including handling, dosing, and conducting drug efficacy studies with mice is required.
• Hands-on experience administering test agents by oral, intravenous, intraperitoneal, and routes, and perform tumor measurements is essential.
• Must have prior experience with minor animal surgery.
• The candidate should have experience in advanced analysis techniques including PK and PK/PD modeling.
• The selected individual will be involved with protocol preparation and raw data transfer.
• He/She will be responsible for the communication of this material verbally, graphically, in written format, or by other appropriate means to department management and other departments.
• This position requires the ability to maintain cell lines in tissue culture, prepare reagents and dosing solutions.
Interested candidates should send their resume to HR@dicerna.com and reference Job Code 08200803 in the e-mail subject line when applying for this position.
Must have a BS or MS in biology or other life science field with a minimum of 2 to 4 years of relevant academic or pharmaceutical laboratory experience. Excellent organizational and record keeping skills, experience with spreadsheet, graphics and word processing applications, the ability to multitask and strong communication and interpersonal skills required. Must have the ability to work independently and as part of a team.
Dicerna Pharmaceuticals is a private, venture-backed biopharmaceutical company developing novel therapeutic agents in multiple therapeutic areas based on its proprietary Dicer Substrate Technology™, which triggers RNA interference (RNAi) in a potent and specific manner. Dicerna has raised significant venture capital led by seasoned biotechnology industry.
Dicerna Pharmaceuticals, Inc. is an Equal Opportunity Employer and as such considers qualified individuals without regard to race, color, religion, sex, sexual preference, age, national origin, or disability.
How to Apply
hr@dicerna.comApplication Instructions / Send a Resume
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness


